Search research articles
Contact Us
Filters
Showing results (1-10 of 22) with videos related to
Page
of 3
Sort By:
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 13, 2016
Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation
Roland Böttger, Daniel Knappe, Ralf Hoffmann
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 6, 2018
PEGylated prodrugs of antidiabetic peptides amylin and GLP-1
Roland Böttger, Daniel Knappe, Ralf Hoffmann
Plos One
|
June 3, 2017
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Böttger, Ralf Hoffmann, Daniel Knappe
Biomaterials
|
June 15, 2021
Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials
Anne Nguyen, Roland Böttger, Shyh-Dar Li
International Journal of Pharmaceutics
|
September 22, 2023
Modification and Delivery of Enkephalins for Pain Modulation
Lukas Hohenwarter, Roland Böttger, Shyh-Dar Li
International Journal of Pharmaceutics
|
October 11, 2022
The mechanism of Hepatocyte-Targeting and safety profile of Phospholipid-Free small unilamellar vesicles
Nojoud Al Fayez, Roland Böttger, Jennifer Brown, et al.
Molecular Pharmaceutics
|
September 21, 2021
Improved Liver Delivery of Primaquine by Phospholipid-Free Small Unilamellar Vesicles with Reduced Hemolytic Toxicity
Nojoud Al Fayez, Roland Böttger, Elham Rouhollahi, et al.
Advanced Drug Delivery Reviews
|
June 24, 2020
Lipid-based nanoparticle technologies for liver targeting
Roland Böttger, Griffin Pauli, Po-Han Chao, et al.
Pharmaceutics
|
October 23, 2021
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
Griffin Pauli, Po-Han Chao, Zhu Qin, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 7, 2019
Phospholipid-Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver
Wunan Zhang, Roland Böttger, Zhu Qin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 22) with videos related to
Sort By:
Page
of 3
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
April 13, 2016
Readily adaptable release kinetics of prodrugs using protease-dependent reversible PEGylation
Roland Böttger, Daniel Knappe, Ralf Hoffmann
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
May 6, 2018
PEGylated prodrugs of antidiabetic peptides amylin and GLP-1
Roland Böttger, Daniel Knappe, Ralf Hoffmann
Plos One
|
June 3, 2017
Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum
Roland Böttger, Ralf Hoffmann, Daniel Knappe
Biomaterials
|
June 15, 2021
Recent trends in bioresponsive linker technologies of Prodrug-Based Self-Assembling nanomaterials
Anne Nguyen, Roland Böttger, Shyh-Dar Li
International Journal of Pharmaceutics
|
September 22, 2023
Modification and Delivery of Enkephalins for Pain Modulation
Lukas Hohenwarter, Roland Böttger, Shyh-Dar Li
International Journal of Pharmaceutics
|
October 11, 2022
The mechanism of Hepatocyte-Targeting and safety profile of Phospholipid-Free small unilamellar vesicles
Nojoud Al Fayez, Roland Böttger, Jennifer Brown, et al.
Molecular Pharmaceutics
|
September 21, 2021
Improved Liver Delivery of Primaquine by Phospholipid-Free Small Unilamellar Vesicles with Reduced Hemolytic Toxicity
Nojoud Al Fayez, Roland Böttger, Elham Rouhollahi, et al.
Advanced Drug Delivery Reviews
|
June 24, 2020
Lipid-based nanoparticle technologies for liver targeting
Roland Böttger, Griffin Pauli, Po-Han Chao, et al.
Pharmaceutics
|
October 23, 2021
Liposomal Resiquimod for Enhanced Immunotherapy of Peritoneal Metastases of Colorectal Cancer
Griffin Pauli, Po-Han Chao, Zhu Qin, et al.
Small (Weinheim an Der Bergstrasse, Germany)
|
September 7, 2019
Phospholipid-Free Small Unilamellar Vesicles for Drug Targeting to Cells in the Liver
Wunan Zhang, Roland Böttger, Zhu Qin, et al.
Page
of 3